Director Morana Jovan-Embiricos resigns from Cullinan Oncology board effective Dec 31, 2021

Cullinan Therapeutics, Inc.

Resignation to dedicate more time to role as Managing Partner of F2 Ventures Ltd. and its portfolio companies.
Decision not due to any disagreement with the Company on operations, policies, or practices.
Resignation effective December 31, 2021; no replacement announced.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Morana Jovan-Embiricos

Director

CGEM · Cullinan Therapeutics, Inc.

Effective: 2021-12-31
Filed: December 29, 2021, 6:59 PM ET

On December 27, 2021, Morana Jovan-Embiricos notified the Board of Directors of Cullinan Oncology, Inc. (the “Company”) of her intention to resign as a director effective as of December 31, 2021

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.9

Morana Jovan-Embiricos departed as Director at Cullinan Therapeutics, Inc..

Action: resigns as director
Role: Director

Exact text from the filing

On December 27, 2021, Morana Jovan-Embiricos notified the Board of Directors of Cullinan Oncology, Inc. (the “Company”) of her intention to resign as a director effective as of December 31, 2021

View on SEC.gov

Cullinan Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-21-368422

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.